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INTRODUCTION
In recent years, the immune response to anaesthesia associ-
ated with surgery has caused attention, and knowledge has
increased and techniques have been improved in other
anaesthesiology-related areas such as endocrine, neuroendo-
crine, cardiovascular, respiratory and metabolic aspects. Re-
search has led to decreased morbidity and mortality from
anaesthesia, but immunologic effects of anaesthesia have
been one of the less investigated areas. Both surgical stress
and anaesthesia are immunosuppressive. Regional anaesthe-
sia perhaps is less suppressive than general anaesthesia.
Some immunologic changes have been reported mainly af-
ter major surgical operations (Lennard et al., 1985;
Procopio et al., 2001). Every component of the immuno-
logic profile can be altered during anaesthesia and surgery.
It has been clearly shown that anaesthetic agents depress the
immune response by compromising phagocytes, lympho-
cyte transformation, cytotoxicity, antibody response to anti-
gen and chemotactic functions of immune cells. The bal-
ance between proinflammatory and anti-inflammatory
processes is of key importance in the reaction of the body to
infection, injury, and surgical trauma. Drugs commonly
used in anaesthesia and intensive care may modulate immu-
nological reactions by influencing intercellular com-
munication through modification of cytokine response and
peripheral immune cells such as natural killer cells, B cells,
and T lymphocyte subpopulations (Brand et al., 2003). Re-
garding postoperative consequences, it is generally believed
that effective perioperative pain management may result in
a more rapid recovery; but the effects of pain relief on post-
operative outcome are difficult to measure due to factors
such as type and duration of surgery, recovery measures, the
analgesics used, their side effects and route of administra-
tion (Rosenberg and Kehlet, 1999). The cytokines have a
major role in the inflammatory response to surgery and
trauma and pain mechanisms. They have local effects of
mediating and maintaining the inflammatory response to tis-
sue injury, and also initiate some of the systemic changes
that occur. After major surgery, the main cytokines released
are interleukin-1 (IL-1), tumour necrosing factor (TNF-)
and interleukin-6 (IL-6). IL-6 is the main cytokine responsi-
ble for inducing the systemic changes known as the acute
phase response. Within 30–60 min after the start of surgery,
IL-6 concentration increases; the change in concentration
becomes significant after 2–4 h. Cytokine production re-
PROCEEDINGS OF THE LATVIAN ACADEMY OF SCIENCES. Section B, Vol. 62 (2008), No. 4/5 (657/658), pp. 141–147.
DOI: 10.2478/v10046-008-0017-y
ANAESTHESIA AND STRESS RESPONSE TO SURGERY
Iveta Golubovska* and Indulis Vanags**
* Hospital of Traumatology and Orthopaedics, Duntes iela 12, Rîga, LV-1005, LATVIA;
E-mail: iveta.golubovska@gmail.com
** Department of Anaesthesiology and Reanimatology, Rîga Stradiòð University, Dzirciema ielâ 16, Rîga, LV-1007, LATVIA
Communicated by Jânis Gardovskis
The body reaction to surgery ranges from minor to massive both locally and generally. General
response is in the form of widespread endocrinal, metabolic and biochemical reactions throughout
the body. Neuro-endocrinal hormone system and inflammation mediators are involved and this
process is called “stress response”. The response has a compensatory mechanism and provides
a maximum chance of survival because of increased cardio-vascular functions, fluid preservation
and supply of increased demands for energy generating substrates. If the stress response is pro-
longed, it may result in exhaustion of essential components of the body, fatigue, decreased resis-
tance, delayed ambulation and increased morbidity and mortality. Suppression of immune
defense mechanisms has been demonstrated in the postoperative period. Such immune compro-
mise can affect the postoperative infection rate, healing process, and the rate and size of tumour
metastases disseminated during surgery. The mechanism of immunosuppression in the post-
operative period is not fully understood. The known mediators of immune depression are neuro-
endocrine response as well as intravenous opioids and inhalational agents, which have shown to
increase the susceptibility to infection through a significant cautions in choosing anaesthetic
agents, to minimise harm to the patients. In this paper we review the data about the influence of
different anaesthetic agents on neuroendocrine, immune and inflammatory response to surgical
stress.
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flects the degree of tissue trauma, so cytokine release is
lowest with the least invasive and traumatic procedures, for
example, laparoscopic surgery. The largest increases in IL-6
occur after major procedures such as joint replacement, ma-
jor vascular and colorectal surgery. After these operations,
cytokine concentrations are maximal at about 24 h and re-
main elevated for 48–72 h postoperatively (Sheeran and
Hall, 1997). Physical well-being after surgery is influenced
by many factors via inflammatory mediators and acute
phase proteins. Multiple regression analysis showed that the
main predictor of worse physical condition at three days
was the size of the C-reactive protein (CRP) response (Hall
et al., 2002). Walking distances in patients after orthopaedic
surgery were more significantly lower in patients with
greater IL-6 and CRP concentrations and patients with
greater CRP had more severe pain on discharge (Hall et al.,
2001). Thus, by promoting IL-6 release we may attenuate
overall physical well-being after major surgery. The
cytokines IL-1 and IL-6 can stimulate secretion of adreno-
corticotropic hormone (ACTH) from isolated pituitary cells
in vitro. In patients after surgery, cytokines may augment
pituitary ACTH secretion and subsequently increase the re-
lease of cortisol. A negative feedback system exists,
whereby glucocorticoids inhibit cytokine production. The
cortisol response to surgery is sufficient to depress IL-6
concentrations (Jameson et al., 1997). By carefully choos-
ing agents we may modify the stress response.
MECHANISM OF STRESS RESPONSE
Tissue and peripheral nerve injury leads to local inflamma-
tory reaction, accompanied by elevated concentrations of
various biological mediators, including prostaglandins,
bradykinins, substance P, calcitonin-G-related protein
(CGRP), and cytokines in the injured tissue (McMahon et
al., 2005), especially proinflammatory cytokines (Wu et al.,
2004; Buvanendran et al., 2006). Peripheral injury is associ-
ated with inflammatory response at the site of the tissue
damage and also in the central nervous system (CNS), in-
cluding peripheral elevation of TNF, IL-1, and IL-6, con-
comitantly with the development of thermal hyperalgesia
and mechanical allodynia (Winkelstein et al., 2001;
Watkins and Maier, 2002). Proinflammatory cytokines, in-
cluding IL-1 and IL-6, can induce peripheral and CNS
sensitisation, leading to pain augmentation (hyperalgesia)
(Watkins et al., 1995).
The mechanisms by which IL-1 contributes to central sensi-
tisation are still not fully understood, but several mediating
processes have been suggested. Many of the same factors
that regulate peripheral hyperalgesia also play a significant
role in central sensitisation. Elevated IL-1 in the CNS also
leads to the production of COX-2 by neurons in the brain
and spinal cord, and promotes synthesis of prostaglandin
(PGE) 2, which is known to increase pain sensitivity
(Samad et al., 2001). Some patients develop very high
cytokine response after surgery and they may benefit from
cytokine inhibition. This may depend on genetic polymor-
phism, and particular genotypes can predispose individuals
to long-term risks (Masterson and Hunter, 1996)
According to stress response, anaesthetics can be grouped
as follows.
GENERAL ANAESTHETICS
The type of general anaesthesia used has no important effect
on the stress response, except for high dose opioid anaesthe-
sia which may inhibit intra- but not postoperative catabolic
hormonal responses (Desborough and Hall, 1989).
Volatile
In some clinical studies, volatile anaesthetics have been as-
sociated with a greater systemic inflammatory response
compared to total intravenous anesthetics with adjuvant nar-
cotic infusion (Crozier et al., 1994; Schneemilch and Band,
2001). In vitro studies have shown that volatile anesthetics
have substantial immunosuppressive effects by inducing
programmed cell death in lymphocytes, diminishing lym-
phocyte function, and altering the distribution of lympho-
cyte cell subsets (Matsuoka et al., 2001; Karabiyik et al.,
2001). Volatile anaesthetic suppressor lymphocyte activity,
which deteriorates host defense, was found to be increased
in the sevoflurane group and decreased in the isoflurane
group postoperatively. Although the differences were insig-
nificant, these results gave the idea that isoflurane caused
less immunosuppression. (Durlu et al., 2002). In contrast, in
the clinical setting of low stress laparoscopic surgery, the
type of volatile anesthetic has been shown to significantly
affect the stress response; the changes associated with sevo-
flurane suggested a more favourable metabolic and immune
response compared to isoflurane (Marana et al., 2003). In
vitro volatile anaesthetics alter relative cytokine concentra-
tions and lymphocyte responses (Woods and Griffits, 1988).
Compared with total intravenous anaesthesia (TIVA), the
T1/T2 ratio decreases significantly after isoflurane anaes-
thesia, but not after propofol anaesthesia. The ratio was sig-
nificantly lower with isoflurane than propofol. Propofol an-
aesthesia promoted the surgical stress-induced adverse
immune response better than isoflurane anaesthesia (Inada
et al., 2004).
INTRAVENOUS ANAESTHETICS
There are huge differences between intravenous agents.
Some of them are given below.
Etomidate
The anaesthetic induction agent etomidate is a carboxylated
imidazole which interferes with the production of steroids
in the adrenal cortex by reversible inhibition of the enzyme
11-hydroxylase and cholesterol side-chain enzyme. The
synthesis of both aldosterone and cortisol is blocked. A sin-
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gle induction dose of the drug will suppress hormone pro-
duction for 6–12 h (Wagner and White, 1984) while infu-
sion for 1–2 h will block cortisol synthesis for up to 24 h. In
healthy patients, there have been observed no adverse car-
diovascular effects from such an infusion during surgery,
and the only metabolic result of cortisol inhibition seen has
been a decrease in the expected glycaemic response. The
widespread use of etomidate as a general anaesthesia induc-
tion agent further supports the suggestion that low levels of
cortisol during surgery are sufficient for surgical survival.
At doses commonly administered for induction of general
anaesthesia, etomidate has been widely and safely used for
decades, often in severe ill patients, despite clear documen-
tation that it lowers cortisol concentrations in peripheral
blood for 8–10 h and that it may continue to inhibit adreno-
cortical synthetic activity for up to 24 h and adrenal respon-
siveness to ACTH even longer (Duthie et al., 1985; Absa-
lom et al., 1999). Intraoperative cortisol concentrations
commonly decrease after etomidate induction to less than
10 mg/dl, documenting that the rapid elevation of cortisol
ordinarily seen during surgery is not necessary for normal
recovery and survival. (Yeager et al., 2005).
Ketamine
There is a growing body of evidence that low-dose
ketamine may play an important role in improving postoper-
ative pain management when used as an adjunct to opioids
or local anaesthetics. Single intraoperative injection of
ketamine (0.15 mg/kg) improved analgesia and passive knee
mobilisation twenty-four hours after arthroscopic anterior
cruciate ligament surgery and improved the postoperative
functional outcome after surgery (Tverskoy et al., 1996;
Menigaux et al., 2000)
Addition of small doses of ketamine before induction of an-
aesthesia resulted in attenuation of secretion of the pro-
inflammatory cytokines IL-6 and TNF-, and in preserva-
tion of IL-2 production at its preoperative level. It is
suggested that this anaesthetic may be of value in prevent-
ing immune function alterations in the early postoperative
period (Beilin et al., 2007).
Propofol
Propofol has earned a prominent place in anaesthesiology
by rapid and profound induction and easy following, useful
secondary properties such as reduction of postoperative
nausea and vomiting. Unfortunately, propofol also has many
side effects, including directly related to the Intralipid vehi-
cle: the ability to support bacterial growth, pain on injec-
tion, hypertriglyceridemia with prolonged infusions, and the
potential for intralipid to compromise the immune response
(Bowdle and Hines, 2002). Data suggest that anaesthesia
with propofol and fentanyl promotes proinflammatory im-
mune responses and influences peripheral lymphocyte com-
position in patients, which may subsequently affect
pathophysiological processes during opioid-based anaesthe-
sia (Brand et al., 2003).
Benzodoazepines
The benzodiazepine, midazolam, which has an imidazole
ring in addition to the basic benzodiazepine structure, sup-
presses the cortisol responses to both peripheral and upper
abdominal surgery. Midazolam and diazepam both inhibit
cortisol production from isolated bovine adrenocortical cells
in vitro. Although Crozier and colleagues showed that sub-
jects produced cortisol in response to exogenous ACTH,
thus confirming that the site of action of the benzodiazepine
is at the hypothalamic–pituitary level, a direct inhibitory ef-
fect on steroid production cannot be excluded (Crozier et
al., 1987).
Opioids
It is unclear whether opioids in the perioperative period pro-
mote or attenuate surgery-induced immunosuppression. It
has been known for many years that opioids suppress hypo-
thalamic and pituitary hormone secretion. It was demon-
strated that therapeutic doses of morphine have the suppres-
sant effect on the hypothalamic–pituitary–adrenal axis in
humans. Morphine suppressed the release of corticotrophin
and, consequently, cortisol in normal and stress conditions,
although the adrenals were found to respond to exogenous
administration of ACTH (Yardeni et al., 2008). In upper ab-
dominal surgery, systemic opioids are relatively ineffective
in preventing the stress response to upper abdominal sur-
gery (Desborough, 2000). Opioids in the perioperative peri-
od can modulate host-defense mechanisms and can either
enhance (Shavit et al., 1984) or suppress tumour metastases.
Several factors may account for these conflicting results.
Immune suppressive effects of opioids have been observed
in pain-free individuals (Yeager et al., 1995) or after the ad-
ministration of relatively moderate to large doses (Beilin et
al., 1996), whereas the beneficial effects of opioids were
observed when administered in an analgesic dose to a host
experiencing postoperative pain. Understanding of endoge-
nous peripheral opioid analgesia has promoted the develop-
ment of clinically useful peripherally acting opioid drugs.
The aim is to produce substances that activate peripheral
opioid receptors, but which do not cross the blood–brain
barrier, thus producing analgesia with less central adverse
effects. Buprenorfin and tramadol are opioids with potential
favourable immune effects.
REGIONAL ANAESTHESIA
During lower extremity or lower abdominal surgical trauma,
for example, epidural block of spinal afferent signals, is as-
sociated with a minimal circulating cytokine response since
neural blockade prevents or markedly limits hypothalamic-
pituitary axis (HPA) activation in these settings (Moller et
al., 1984; Naito et al.,1992; Moore et al., 1994; Lattermann
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et al., 2003) However, it fails to limit HPA activation dur-
ing other types of surgery (upper abdominal or thoracic)
that are associated with substantial cytokine release (Naito
et al., 1992; Norman and Fink, 1997)
Local anaesthetics can reduce the postoperative inflamma-
tory response in two ways: they block neural transmission
at the site of tissue injury and decrease the neurogenic in-
flammation (Coderre et al., 1993); they also have systemic
anti-inflammatory properties of their own (Hollmann and
Durieux, 2000).
It seems that only regional anaesthesia techniques can lead
to long stress response reduction. Preferably we should use
continuous techniques, and for example epidural anaesthe-
sia should last at least 24–48 hours (Kehlet, 1998; 2000).
Epidural anaesthesia avoids the depressed mitogen-induced,
lymphocyte-proliferative responses normally seen in pa-
tients in general anaesthesia (Whelan et al., 1982) There has
been observed a significant difference in IL-6 production
among the patient controlled analgesia (PCA), patient- con-
trolled epidural analgesia (PCEA) and intermittent opiates
regimen (IOR) at 72 hours. IL-6 levels were least increased
in the PCEA group, almost returning to preoperative values
by 72 h. In contrast, IL-6 levels were most increased in the
IOR group and still increasing at 72 h, whereas in the PCA
group IL-6 levels were intermediate (Beilin et al., 2003).
An attempt to suppress the markers of the inflammatory re-
sponse using continuous intense epidural blockade with lo-
cal anaesthetics has not been successful, showing that neu-
roaxial blockade with local anaesthetics cannot prevent
systemic and local inflammatory reaction (Moore et al.,
1994). Some authors have found that nerve blocks, particu-
larly continuous lumbar plexus and sciatic nerve blocks sig-
nificantly inhibit CRP and IL-6 (Bagry et al., 2008). Other
authors have found similar effects of general and spinal an-
aesthesia on stress response in patients undergoing surgery.
Perioperative levels of TNF, IL-6, CRP are comparable in
both types of anaesthesia (Buyukkocak et al., 2006).
DIFFERENT DRUGS
Glucocorticoids
Recently, glucocorticoids, which block several proinflam-
matory substances (cytokines, complement, arachidonic
acid cascade) have been studied in elective surgery proce-
dures. These results suggest that large preoperative doses of
methylprednisolone reduce pain, hyperthermia, IL-6 and
PGE responses, and improve pulmonary function (Schulze
et al., 1992).
More recent research reported glucocorticoid-induced
stimulatory effects on a variety of inflammatory response
components. These effects were usually observed at low
glucocorticoid concentrations, close to concentrations that
are observed in vivo during basal, unstimulated states. It
seems clear that the long-held clinical view that gluco-
corticoids act solely as anti-inflammatory agents needs to be
reassessed. Varying doses of glucocorticoids do not lead
simply to varying degrees of inflammation suppression, but
rather glucocorticoids can exert a full range of effects from
permissive to stimulatory to suppressive (Munck and
Naray-Fejes-Toth, 1992; Yeager et al., 2005). Gluco-
corticoids have been shown to induce or enhance the ex-
pression of several cytokine receptors, including those for
TNF-a, IL-1, IL-2, IL-6, interferon - (IGF) (Almawi et
al.,1996; Wiegers and Reul, 1998).Glucocorticoid effects
on cytokine receptors were shown to be specific to
glucocorticoids as the effects are not seen with other steroid
molecules (mineralcorticoids). Surgical stress-induced pro-
duction of brain PGE2 is specifically regulated by gluco-
corticoid via the mediation of type II corticosteroid recep-
tors. Normal IL-1 signalling is required for the production
of brain PGE2 under basal conditions and in response to
surgical stress (Beilin et al., 2006).
Clonidine
Clonidine is a centrally acting antihypertensive drug. Injec-
tion of the 2-adrenoreceptor agonist clonidin reduces pain
behaviour and local tissue proinflammatory cytokine con-
centration (Romero-Sandoval et al., 2005). Clonidine was
observed to change the ratio of T-lymphocyte subpopu-
lations in peripheral blood in favour of a proinflammatory
response, which might be favourable for maintaining im-
mune balance after surgery. T1/T2 ratios were significantly
lower 6 h after cardiac surgery with clonidine compared to
placebo. A possible explanation might be that clonidine, by
reducing sympathetic tone via 2-adrenoreceptors, changed
the early T-cell subset response in favor of the proinflam-
matory response after cardiac surgery. This might be impor-
tant for maintaining immune balance perioperatively. How-
ever, the systemic inflammatory response was not affected
by clonidine in this study (von Dossow et al., 2006). The ef-
fects of intravenous and epidural clonidine, 4 g/kg, com-
bined with epidural morphine, 40 g/kg, on the neuro-
endocrine and immune stress responses to thoracic surgery
have been reported. Catecholamines did not change in any
of the groups. Total leukocyte and neutrophil counts were
increased in all groups at the end of surgery, but increase
was least in the epidural clonidine group. The number of
lymphocytes was reduced at the end of surgery in the
epidural and intravenous group, compared with the control
group in which the number of lymphocytes did not change.
The effects were more pronounced with epidural than with
intravenous administration. We may conclude that clonidine
can modulate the immune stress response to thoracic sur-
gery (Novak-Jankovich et al., 2000).
Other authors have found no significant differences in
plasma epinephrine or cortisol levels between clonidine and
placebo groups. With a clinical dose, clonidine did not pre-
vent postoperative lymphocyte depletion. 2-agonists may
not suppress adrenocortical stress responses sufficiently to
prevent postoperative immune suppression (Ellis et al.,
2002).
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Clonidine provides haemodynamic stability through its
sympatholytic activity, and can reduce anaesthetic and anal-
gesic requirements and provide sedation. By reducing the
sympathoadrenal and cardiovascular responses caused by
noxious surgical stimuli, the 2-agonists inhibit the stress
responses mediated by the sympathetic nervous system
(Antaa and Scheinin, 1993).
Physostigmine
Continuous infusion of physostigmine combined with mor-
phine-based PCA in the postoperative period significantly
reduced opiate consumption, and enhanced the analgesic re-
sponse. Patients in the physostigmine group exhibited sig-
nificantly reduced ex vivo production of the proinflam-
matory cytokine, IL-1. The finding that patients treated
with physostigmine exhibited decreased production of
IL-1 may be explained by the fact that physostigmine
crosses the blood-brain barrier, elevates acetylcholine levels
in the brain, and thereby activates the cholinergic anti-in-
flammatory pathways (Beilin et al., 2005).
POSTOPERATIVE PAIN MANAGEMENT
Non-steroidal antiinflammatory drugs (NSAID) are used
widely for perioperative pain control but have a poor effect
on surgical stress responses (Kehlet, 1998). By sparing
physiological tissue prostaglandin production, and while in-
hibiting inflammatory prostaglandin release, cyclooxyge-
nase(COX)-2 inhibitors offer the potential of effective anal-
gesia with fewer side effects than the NSAID, but the
desired outcome has been achieved only partially (Power et
al., 2004; Botting et al., 2003). The mechanism of paraceta-
mol action remains unclear as, respectively, paracetamol has
no known endogenous binding sites and does not inhibit pe-
ripheral cyclooxygenase activity significantly. There is in-
creasing evidence of a central antinociceptive effect, and
potential mechanisms for this include inhibition of a central
nervous system COX-2, inhibition of a putative central cy-
clooxygenase ‘COX-3’ that is selectively susceptible to
paracetamol, and modulation of inhibitory descending sero-
tinergic pathways (Bonnefont et al., 2003). Paracetamol has
also been shown to prevent prostaglandin production at the
cellular transcriptional level, independent of cyclooxyge-
nase activity.
CONCLUSIONS
The neuroendocrine response to stress is an important modi-
fier of immune function, and anxiety, fear, and pain have
been shown to be associated with adverse outcomes. There
is a lot of data on modification of stress hormone responses
by anaesthetic drugs, but very few studies relating hormone
levels to long-term outcome have been done. Stress hor-
mones like norepinephrine can trigger a pronounced and
immediate activation of pro-inflammatory cells and cytoki-
nes. The triggers for stress responses are both psychological
and physical, so it seems reasonable that postoperative im-
mune function could be improved by increased attention to
perioperative anxiolysis and analgesia.
The influence of anaesthetic agents on stress response is
summarised in Table 1. It will be important to “measure”
inflammation by analysis of appropriate serum markers.
Measuring inflammation at a preoperative baseline may sig-
nificantly improve the accuracy with which we stratify pa-
tients for operative risk. The markers of inflammation and
CRP have a high predictive utility in determining the clini-
cal course. It is also possible that a postoperative profile of
these bio-markers may identify patients who would benefit
from more sustained anti-inflammatory treatment strategies
(Fig. 1).
T a b l e 1
INFLUENCE OF DIFFERENT ANAESTHETIC AND ANALGESIC
AGENTS ON STRESS RESPONSE TO SURGERY
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Minimising duration and intensity of perioperative
inflammatory response
Fig. 1. Strategies minimising perioperative stress response.
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ANESTÇZIJAS IETEKME UZ ORGANISMA ATBILDI ÍIRURÌISKAJAM STRESAM
Organisma atbilde uz íirurìisko iejaukðanos variç no minimâlas lîdz ïoti izteiktai, ar izmaiòâm gan grieziena vietâ, gan visâs orgânu
sistçmâs. Viscaur organismâ notiek plaðas neiroendokrînâs, metabolâs un bioíîmiskâs reakcijas. Neiroendokrînâs hormonu sistçmas un
iekaisuma mediatoru iesaistîðanos ðajâ procesâ sauc par “stresa atbildi”. Ðai atbildei ir kompensçjoðs mehânisms, un tas maksimâli palielina
izdzîvoðanas iespçjas, paâtrinot kardiovaskulârâs sistçmas darbîbu, palielinot ðíidruma uzkrâðanu un enerìçtiskâs vajadzîbas. Ja ðîs stresa
reakcijas âtri nebeidzas, iestâjas visu galveno organisma sistçmu izsîkums, attîstâs nogurums, samazinâs pretestîba infekcijâm, ir novçlota
izrakstîðanâs no slimnîcas, pieaug mortalitâte un morbiditâte. Seviðíi gribam uzsvçrt imûnsistçmas aizsargmehânismu izsîkumu
pçcoperâcijas periodâ. Tas var ietekmçt infekciozo komplikâciju risku, dzîðanas procesus un audzçju metastâþu diseminâciju.
Imûnsupresijas mehânismi vçl nav lîdz galam izpçtîti, bet ir pierâdîts, ka atseviðíâs anestçzijas vielas, kâ, piemçram, inhalâcijas anestçtiíi
un intravenozi ievadâmie opioîdi palielina noslieci uz infekciozâm komplikâcijâm, samazinot atbildîgo ðûnu citotoksisko aktivitâti. Tâtad
mums ir jâbût piesardzîgiem, izvçloties anestçzijas veidu un anestçtiíus, lai nodarîtu iespçjami mazâku kaitçjumu organismam. Rakstâ ir
apkopota literatûra par daþâdu anestçtiíu izmantoðanu un to ietekmi uz organisma neiroendokrîno, imûno un iekaisîgo atbildi íirurìiskajam
stresam.
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